ResearcherUniversity of BernActive in the last 2 years
José A. Galván
Matched on ORCID iD 0000-0003-3138-7642; OpenAlex author ID A5009846567. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 6
- Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heteroge… Co-author DOI 10.1038/s41416-025-02959-w↗
- Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-023-35796-7↗
- A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.cell.2019.03.010↗
- PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. Co-author DOI 10.1016/j.ejca.2016.06.013↗
- Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal … Co-author DOI 10.1038/bjc.2015.177↗
- Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer. First author DOI 10.1371/journal.pone.0078327↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martin Wartenberg · 5 shared papers, 2015–2025 · strength 0.59
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. DOI 10.1038/s41467-023-35796-7↗
- Paper A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. DOI 10.1016/j.cell.2019.03.010↗
- Eva Karamitopoulou · 5 shared papers, 2015–2025 · strength 0.59
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. DOI 10.1038/s41467-023-35796-7↗
- Paper A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. DOI 10.1016/j.cell.2019.03.010↗
- Aurel A. Perren · 3 shared papers, 2015–2025 · strength 0.39
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Paper PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metas… DOI 10.1016/j.ejca.2016.06.013↗
- Alessandro Lugli · 3 shared papers, 2015–2025 · strength 0.39
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Paper PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metas… DOI 10.1016/j.ejca.2016.06.013↗
- Beat Gloor · 3 shared papers, 2015–2025 · strength 0.39
- Paper Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour… DOI 10.1038/s41416-025-02959-w↗
- Paper Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotyp… DOI 10.1038/bjc.2015.177↗
- Paper PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metas… DOI 10.1016/j.ejca.2016.06.013↗
- Nikki K. Lytle · 2 shared papers, 2019–2023 · strength 0.20
- Lesley Paige Ferguson · 2 shared papers, 2019–2023 · strength 0.20
- Nirakar Rajbhandari · 2 shared papers, 2019–2023 · strength 0.20
- Andrew M. Lowy · 2 shared papers, 2019–2023 · strength 0.20
- Tannishtha Reya · 2 shared papers, 2019–2023 · strength 0.20
- Pawan Noel · 1 shared paper, 2019 · strength 0.06
- Wei Lin · 1 shared paper, 2019 · strength 0.06
- Raymond G. Fox · 1 shared paper, 2019 · strength 0.06
- Haiyong Han · 1 shared paper, 2019 · strength 0.06
- Daniel D. Von Hoff · 1 shared paper, 2019 · strength 0.06
- Erik Vassella · 1 shared paper, 2016 · strength 0.05
- Carmen García-Pravia · 1 shared paper, 2013 · strength 0.03
- Luis Barneo Serra · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.